allergan report non-gaap ep revenu compar street
estim respect notabl target net debt/ebitda
continu believ manag take far aggress
approach de-lever bear mind net debt/latest twelv month ebitda
busi face myriad headwind gener exposur competit
headwind botox migrain manag rel tepid approach de-lever
may logic one believ pipelin return busi sustain
growth howev continu take opposit view recent data abicipar
case point refer note detail reiter neutral rate
rais pt owe modest estim revis
upward revis guidanc mainli function time restasi
gener recal previous cite two ep guidanc rang rang
reflect restasi gener competit start may
juli rang reflect competit start
april juli fact competit yet materi isnt surpris
us given underli complex associ formul ophthalm
emuls regulatori delay associ gener case point
said matter time competit materi
quick thought current approach de-lever manag stanc
toward debt pay continu focu share buyback anoth
author underscor rel tepid approach improv capit structur
one continu believ lack sens urgenc given believ
signific risk surround pipelin henc need add higher-qu
street estim bit gener street top-lin estim
impli year-over-year growth surmis estim
factor signific eros restasi time-frame
mind would appear estim reflect continu meaning growth
botox therapeut perhap start contribut ubrogep abicipar
kind dynam overli optimist view instanc regard botox
migrain though made clear amgen aimovig impact
earli launch work execut payer contract asid
express script note publicli aimovig price point respons see
addit anti-cgrp entrant physician check suggest potenti
pressur botox refer note detail
risk includ competit pressur key product
allergan focus brand across rang therapeut categori
dilut cash ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
actual versu pjc consensu estim
consensu estim
compani report first call pjc estim
compani report pjc estim
consensu
compani report pjc estim
page
million except per shareactualspjc estimatesstreet estim gener net except per share guidanceguidanceestimatesadjust total gross sg net interest expense/oth tax rate share ep except per total ep exhibit
reflect restasi gener entrant begin fall
consensu estim
compani report first call pjc estim
slightli rais pt agn
new pt base price-to-earnings unchang ep estim
discount unchang one year unchang revis
estim reflect restasi gener competit start fall also reflect
greater contribut vraylar linzess estim also reflect slightli lower share
count given recent author addit share buyback new pt
impli ebitda multipl given myriad headwind face
compani name signific exposur loss exclus competit headwind face botox
migrain set view myriad uncertainti surround late-stag
pipelin continu believ visibl signific long-term organ ebitda growth
limit mind believ well posit multipl expans
page
million except per medic medic neuro special central nervou women establish gener medicin intern world-wide product gener expens incom net
compani report pjc estim
page
fiscal year end decemb million except central nervou systemnamenda central nervou women lo women women establish establish establish gener medicin exhibit
compani report pjc estim
page
fiscal year end decemb million except medic aestheticsbotox fillers/juvederm regen medic medic medic dermatolog includ medic neuro urologybotox neuro neuro special allergan quarterli annual incom statement
million except ep
sale
sell gener administr
incom loss tax
cog product revenu
sale
expens total revenu
sell gener administr
sell gener administr
reflect restasi gener entrant begin
began report anda segment revenu discontinu oper start compani also report deduct repres product sold anda expect report deduct well
histor quarterli result pre may compar due divestitur anda segment
began report line item perform net incom begin metric calcul result chang
proprietari piper jaffray juli
current disclosur inform compani found
